(Q43540832)

English

Risk of myocardial infarction and death associated with the use of nonsteroidal anti-inflammatory drugs (NSAIDs) among healthy individuals: a nationwide cohort study

scientific article published on 5 November 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 November 2017

Risk of myocardial infarction and death associated with the use of nonsteroidal anti-inflammatory drugs (NSAIDs) among healthy individuals: a nationwide cohort study (English)

1 reference

Europe PubMed Central

24 November 2017

myocardial infarction

1 reference

based on heuristic

inferred from title

Gunnar Hilmar Gislason

2

1 reference

Europe PubMed Central

24 November 2017

object named as

F Folke

4

0 references

Christian Torp-Pedersen

15

object named as

C Torp-Pedersen

1 reference

Europe PubMed Central

24 November 2017

14

object named as

L Køber

1 reference

Europe PubMed Central

24 November 2017

5

object named as

M L Hansen

1 reference

Europe PubMed Central

24 November 2017

author name string

E L Fosbøl

1

1 reference

Europe PubMed Central

24 November 2017

S Jacobsen

3

1 reference

Europe PubMed Central

24 November 2017

T K Schramm

6

1 reference

Europe PubMed Central

24 November 2017

R Sørensen

7

1 reference

Europe PubMed Central

24 November 2017

J N Rasmussen

8

1 reference

Europe PubMed Central

24 November 2017

S S Andersen

9

1 reference

Europe PubMed Central

24 November 2017

S Z Abildstrom

10

1 reference

Europe PubMed Central

24 November 2017

J Traerup

11

1 reference

Europe PubMed Central

24 November 2017

H E Poulsen

12

1 reference

Europe PubMed Central

24 November 2017

S Rasmussen

13

1 reference

Europe PubMed Central

24 November 2017

language of work or name

0 references

publication date

5 November 2008

1 reference

Europe PubMed Central

24 November 2017

Clinical Pharmacology & Therapeutics

1 reference

Europe PubMed Central

24 November 2017

85

1 reference

Europe PubMed Central

24 November 2017

2

1 reference

Europe PubMed Central

24 November 2017

190-197

1 reference

Europe PubMed Central

24 November 2017

The pattern of use of non-steroidal anti-inflammatory drugs (NSAIDs) from 1997 to 2005: a nationwide study on 4.6 million people

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.204

21 January 2018

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.204

21 January 2018

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.204

21 January 2018

Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.204

21 January 2018

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.204

21 January 2018

The coronary risk of cyclo-oxygenase-2 inhibitors in patients with a previous myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.204

21 January 2018

Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.204

21 January 2018

Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.204

21 January 2018

Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.204

21 January 2018

Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.204

21 January 2018

Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.204

21 January 2018

Risk of Death or Reinfarction Associated With the Use of Selective Cyclooxygenase-2 Inhibitors and Nonselective Nonsteroidal Antiinflammatory Drugs After Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.204

21 January 2018

Differences in outcomes of patients with congestive heart failure prescribed celecoxib, rofecoxib, or non-steroidal anti-inflammatory drugs: population based study

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.204

21 January 2018

Non-steroidal anti-inflammatory drugs and risk of first hospital admission for heart failure in the general population

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.204

21 January 2018

Risk of cardiovascular events and rofecoxib: cumulative meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.204

21 January 2018

Risk of cardiovascular events associated with selective COX-2 inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.204

21 January 2018

Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.204

21 January 2018

Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.204

21 January 2018

Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.204

21 January 2018

Blunting of the cardiovascular effect of aspirin by ibuprofen: what is the evidence?

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.204

21 January 2018

Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.204

21 January 2018

What therapies have replaced rofecoxib in Ireland?

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.204

21 January 2018

Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.204

21 January 2018

NSAID use and the risk of hospitalization for first myocardial infarction in the general population: a nationwide case-control study from Finland

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.204

7 January 2021

based on heuristic

inferred from DOI database lookup

Toward individualized analgesic therapy: functional cyclooxygenase 1 and 2 haplotypes

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.204

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular and cerebrovascular events in the randomized, controlled Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.204

7 January 2021

based on heuristic

inferred from DOI database lookup

The case-crossover design: a method for studying transient effects on the risk of acute events

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.204

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/CLPT.2008.204

1 reference

Europe PubMed Central

24 November 2017

1 reference

Europe PubMed Central

24 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43540832&oldid=2098195457"